Fabio Agnelli

468 total citations
10 papers, 391 citations indexed

About

Fabio Agnelli is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Fabio Agnelli has authored 10 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 3 papers in Organic Chemistry. Recurrent topics in Fabio Agnelli's work include Microbial Natural Products and Biosynthesis (4 papers), RNA and protein synthesis mechanisms (3 papers) and RNA modifications and cancer (2 papers). Fabio Agnelli is often cited by papers focused on Microbial Natural Products and Biosynthesis (4 papers), RNA and protein synthesis mechanisms (3 papers) and RNA modifications and cancer (2 papers). Fabio Agnelli collaborates with scholars based in United States and Italy. Fabio Agnelli's co-authors include Gary A. Sulikowski, R. Michael Corbett, Paul Spencer, R Reddy, James R. Williamson, Basma Yacoubi, Manal A. Swairjo, Paul Schimmel, Valérie de Crécy‐Lagard and B. Nordin and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Fabio Agnelli

10 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabio Agnelli United States 10 229 181 58 42 31 10 391
Gordon Bruton United Kingdom 10 187 0.8× 158 0.9× 29 0.5× 41 1.0× 16 0.5× 14 358
TSUNEAKI HIDA Japan 12 161 0.7× 211 1.2× 143 2.5× 17 0.4× 47 1.5× 20 372
Monica H. Palme United States 9 181 0.8× 166 0.9× 98 1.7× 56 1.3× 56 1.8× 9 359
Jörg Fohrer Germany 13 245 1.1× 116 0.6× 102 1.8× 34 0.8× 37 1.2× 26 377
Anatol P. Spork Germany 13 271 1.2× 184 1.0× 68 1.2× 35 0.8× 11 0.4× 16 380
Xiuling Chi United States 10 240 1.0× 98 0.5× 116 2.0× 32 0.8× 12 0.4× 10 352
Robert F. Keyes United States 11 156 0.7× 147 0.8× 36 0.6× 21 0.5× 18 0.6× 21 312
Andrew M. Giltrap Australia 12 351 1.5× 287 1.6× 129 2.2× 52 1.2× 44 1.4× 20 533
Dominique Cartier France 13 203 0.9× 233 1.3× 42 0.7× 12 0.3× 25 0.8× 41 468
Hermann Führer Switzerland 14 207 0.9× 232 1.3× 145 2.5× 18 0.4× 43 1.4× 29 430

Countries citing papers authored by Fabio Agnelli

Since Specialization
Citations

This map shows the geographic impact of Fabio Agnelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Agnelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Agnelli more than expected).

Fields of papers citing papers by Fabio Agnelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Agnelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Agnelli. The network helps show where Fabio Agnelli may publish in the future.

Co-authorship network of co-authors of Fabio Agnelli

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Agnelli. A scholar is included among the top collaborators of Fabio Agnelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Agnelli. Fabio Agnelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yacoubi, Basma, R Reddy, B. Nordin, et al.. (2009). The universal YrdC/Sua5 family is required for the formation of threonylcarbamoyladenosine in tRNA. Nucleic Acids Research. 37(9). 2894–2909. 130 indexed citations
2.
Agnelli, Fabio, Steven J. Sucheck, David Rabuka, et al.. (2004). Dimeric Aminoglycosides as Antibiotics. Angewandte Chemie International Edition. 43(12). 1562–1566. 56 indexed citations
3.
Agnelli, Fabio, Steven J. Sucheck, David Rabuka, et al.. (2004). Dimeric Aminoglycosides as Antibiotics. Angewandte Chemie. 116(12). 1588–1592. 11 indexed citations
4.
Sulikowski, Gary A., et al.. (2002). Progress toward a Biomimetic Synthesis of Phomoidride B. Organic Letters. 4(9). 1451–1454. 11 indexed citations
5.
Sulikowski, Gary A., Fabio Agnelli, Paul Spencer, John M. Koomen, & David H. Russell. (2002). Studies on the Biosynthesis of Phomoidride B (CP-263,114):  Evidence for a Decarboxylative Homodimerization Pathway. Organic Letters. 4(9). 1447–1450. 18 indexed citations
6.
Zanoni, Giuseppe, et al.. (2001). Enantioselective syntheses of isoprostane and iridoid lactones intermediates by enzymatic transesterification. Tetrahedron Asymmetry. 12(12). 1779–1784. 20 indexed citations
7.
Spencer, Paul, Fabio Agnelli, & Gary A. Sulikowski. (2001). Investigations into the Production and Interconversion of Phomoidrides A−D. Organic Letters. 3(10). 1443–1445. 29 indexed citations
8.
Sulikowski, Gary A., Fabio Agnelli, & R. Michael Corbett. (1999). Investigations into a Biomimetic Approach toward CP-225,917 and CP-263,114. The Journal of Organic Chemistry. 65(2). 337–342. 49 indexed citations
9.
Spencer, Paul, Fabio Agnelli, Howard J. Williams, Nancy P. Keller, & Gary A. Sulikowski. (1999). Biosynthetic Studies on the Fungal Secondary Metabolites CP-225,917 and CP-263,114. Journal of the American Chemical Society. 122(2). 420–421. 19 indexed citations
10.
Agnelli, Fabio & Gary A. Sulikowski. (1998). Synthesis of arylacetates by the palladium-catalyzed cross-coupling of aryl bromides and copper(II) enolates. Tetrahedron Letters. 39(48). 8807–8810. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gordon Bruton Breakdown of academic impact, for papers by TSUNEAKI HIDA Breakdown of academic impact, for papers by Monica H. Palme Breakdown of academic impact, for papers by Jörg Fohrer Breakdown of academic impact, for papers by Anatol P. Spork Breakdown of academic impact, for papers by Xiuling Chi Breakdown of academic impact, for papers by Robert F. Keyes Breakdown of academic impact, for papers by Andrew M. Giltrap Breakdown of academic impact, for papers by Dominique Cartier Breakdown of academic impact, for papers by Hermann Führer
Rankless by CCL
2026